Central Trust & Investment »

Immunitybio shares owned by Central Trust & Investment

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Central Trust & Investment from 13F filings

Historical chart of Central Trust & Investment investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Central Trust & Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Central Trust & Investment

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.4k 1.0k 5.37
2023-12-31 $5.0k 1.0k 5.02

More positions owned by Central Trust & Investment

Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Schwab Strategic Tr Us Tips Etf (SCHP)
Sprott Physical Gold Tr Unit (PHYS)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Msci Emrg Chn (EMXC)
Broadcom (AVGO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Gold Tr Ishares New (IAU)
O'reilly Automotive (ORLY)

View all positions for Central Trust & Investment

Top funds holding Immunitybio

Vanguard Group
Credit Suisse
Jpmorgan Chase & Co
Goldman Sachs Group
Charles Schwab Investment Management
Bank of America Corporation
Jane Street
D. E. Shaw & Co
Barclays
Citadel Advisors
Bank of New York Mellon
Bsc Private Wealth Management
Citigroup
Bank Of Montreal
Alliancebernstein

View all funds holding Immunitybio